Ocular Oncology
The Ocular Oncology Service provides a broad range of diagnostic, medical
and surgical services. The service specializes in the treatment of choroidal
melanoma and other ocular tumors in adults, treatment of retinoblastoma
and other ocular tumors in children and new treatment methodologies
for intraocular tumors.
 |
Ronald L. Green,
M.D.
Dr. Green earned an M.D. and completed his residency at Wayne
State University. He completed a fellowship in ophthalmic diagnostic
ultrasound at the University of Iowa. Dr. Green has been Medical
Director for the Doheny Eye Institute's Ultrasound Laboratory
for the past ten years. He is the author of numerous papers and
a major textbook on this subject. Dr. Green is now one of the
most prominent ocular ultrasound experts in the world, and his
recent comprehensive text is a classic in the field. He has participated
in studies involving ocular trauma, intraocular tumors, orbital
tumors and biometry for intraocular lens calculations. Dr. Green
is a Professor at the USC Keck School of Medicine. |
| |
|
 |
A. Linn Murphree, M.D.
Dr. Murphree earned an M.D. from Baylor College of Medicine.
He completed three fellowships: one at the University of Copenhagen,
another at Baylor College of Medicine, and the third at Wilmer
Ophthalmological Institute, Johns Hopkins Hospital. Dr. Murphree
is a Professor of Ophthalmology and Pediatrics at the USC Keck
School of Medicine and leads the development of a world-class
Ocular Oncology Service at Childrens Hospital of Los Angeles and
at the Doheny Eye Institute. Dr. Murphree and his colleagues have
also developed new protocols for the treatment of retinoblastoma.
He co-chairs the Retinoblastoma Study (RBS), a planned international
multicenter clinical trial.
|
| |
|
 |
Thomas C. Lee, M.D.
Dr. Thomas C. Lee specializes in retinopathy of prematurity and retinoblastoma, along with other challenging retinal diseases. Dr. Lee earned his bachelor's at Johns Hopkins University and received his MD from Cornell University where he graduated with Honors in Research as a Howard Hughes Scholar. He completed his ophthalmology residency at Cornell and then went to Harvard Medical School as a Heed Fellow where he studied retinal stem cells and the role they play in cancer. He completed his retina fellowship at Massachusetts Eye and Ear Infirmary, Harvard Medical School before returning to Cornell where he was a Fred Gluck Scholar. He is an assistant professor of clinical ophthalmology at the Keck School of Medicine of the University of Southern California (USC), attending physician at the Doheny Eye Institute at USC and is director of the Retina Institute at Childrens Hospital Los Angeles.
|
| |
|
 |
Narsing A. Rao, M.D.
Dr. Rao earned an M.D. from Osmania University. He completed
two residencies, one in pathology and one in ophthalmology at
the Georgetown University Medical Center. He completed his fellowship
in ophthalmic pathology at the Armed Forces Institute of Pathology.
Dr. Rao is Director of the Inflammation, Uveitis, and AIDS Service
and Director of the A. Ray Irvine, Jr., Ophthalmic Pathology Laboratory
at Doheny, which is the cornerstone of the teaching program for
the residents. Dr. Rao is involved in both the research aspects
and clinical treatment of a broad range of inflammatory ocular
diseases and tumors. Specialized medical and surgical clinical
protocols are utilized to treat resistant cases of uveitis. The
special drug regimen includes the use of cyclosporine, cytoxan
and other immunosuppressives.
|
|